Tag: elections

Posts with tag: elections

Latest Posts

Google's Retreat from Diversity Hiring Targets Amidst Scrutiny

Google and Meta eliminate diversity hiring targets as legal pressure intensifies, while Apple, Microsoft, and JPMorgan Chase maintain their efforts.

American Superconductor Reports Q3 Profit

American Superconductor Corp. (AMSC) reports a fiscal third-quarter net income of $2.5 million, compared to a loss in the same period last year.

The Future of AI: Big Tech's Earnings Season and the Race to Invest in Artificial Intelligence

Big Tech's earnings season winds down with AI taking center stage. Microsoft, Meta, and Google report mixed results, but analysts remain bullish on their long-term AI bets. Nvidia's earnings report on Feb. 26 is seen as a key indicator for AI stocks.

LG CNS's Seoul Debut Falls Flat as IPO Market Sentiment Sours

South Korea's LG CNS debuts on the Seoul exchange with a weak start, falling 8.6% on its first day of trading, despite a strong IPO. This reflects growing skepticism among investors about the profitability of IPOs in Seoul.

AMD Stock Dips After Q4 Beat, Despite Better-Than-Expected Q1 Forecast

AMD shares fall despite beating earnings expectations, while Nvidia and Intel shares fluctuate amid concerns over tariffs and AI competition.

AMD Beats Estimates, but Shares Drop Amid Tariff Concerns

AMD Beats Earnings, but Stock Drops After Hours

Palantir Soars on Strong Q4 Earnings, Upgrading Outlook

Palantir stock soars 20.92% despite missing next quarter revenue guidance as it reports impressive fourth-quarter results exceeding analysts' billings, revenue, and EPS estimates. Palantir's growth outlook remains encouraging.

Merck Earnings Miss on 2025 Guidance, Stock Drops

Merck reported Q4 and full-year earnings in line with estimates. Sales rose 7% to $64.2 billion in 2024, while EPS was $7.65. However, the stock dropped 8% pre-market due to weaker-than-expected 2025 guidance, indicating only a slight increase in revenue compared to 2024. Analysts have raised concerns about Merck's pipeline and competition, while comparing it to Pfizer, which also reported earnings on Tuesday and showed positive long-term potential. Merck's key revenue drivers include Gardasil and Keytruda, but Gardasil has faced challenges in China and Keytruda's patent expires in 2028.

Jevons Paradox: Why AI Boom May Continue Despite China's DeepSeek

Artificial intelligence stocks may have further to run despite the emergence of China's cheap AI model DeepSeek, according to the Jevons Paradox.

TikTok Sale Draws 'Great Interest'

Interest abounds regarding the sale of TikTok as the U.S. administration seeks to broker a deal.